Farkas Sükösd

866 total citations
45 papers, 588 citations indexed

About

Farkas Sükösd is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Farkas Sükösd has authored 45 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 15 papers in Surgery and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Farkas Sükösd's work include Renal cell carcinoma treatment (10 papers), Renal and related cancers (9 papers) and Cancer Genomics and Diagnostics (7 papers). Farkas Sükösd is often cited by papers focused on Renal cell carcinoma treatment (10 papers), Renal and related cancers (9 papers) and Cancer Genomics and Diagnostics (7 papers). Farkas Sükösd collaborates with scholars based in Hungary, Germany and Finland. Farkas Sükösd's co-authors include Gyula Kovács, Mónica Wilhelm, Lajos Haracska, Amrit Pal Kaur, Naoto Kuroda, Börje Ljungberg, Attila Fazekas, Edward C. Jones, Péter Horváth and Tamás Magyarlaki and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Farkas Sükösd

41 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farkas Sükösd Hungary 14 348 169 168 88 82 45 588
Luca Ventura Italy 16 378 1.1× 132 0.8× 142 0.8× 102 1.2× 239 2.9× 59 735
Alissa Minkovsky United States 6 258 0.7× 114 0.7× 112 0.7× 61 0.7× 123 1.5× 7 542
Dali Huang United States 13 283 0.8× 119 0.7× 268 1.6× 83 0.9× 185 2.3× 18 777
Cosetta Ravelli Italy 16 522 1.5× 110 0.7× 48 0.3× 87 1.0× 107 1.3× 44 822
Eun Hee Lee South Korea 17 291 0.8× 139 0.8× 97 0.6× 77 0.9× 165 2.0× 46 676
Xi Zhan China 11 468 1.3× 80 0.5× 160 1.0× 47 0.5× 82 1.0× 28 841
Joanna Budna Poland 15 304 0.9× 168 1.0× 111 0.7× 56 0.6× 170 2.1× 60 737
Nuran Bektas Germany 13 642 1.8× 132 0.8× 103 0.6× 114 1.3× 269 3.3× 15 1.0k
Shufang Renault France 11 253 0.7× 322 1.9× 112 0.7× 55 0.6× 210 2.6× 17 683
Víctor González‐Rumayor Spain 10 277 0.8× 203 1.2× 93 0.6× 22 0.3× 87 1.1× 16 478

Countries citing papers authored by Farkas Sükösd

Since Specialization
Citations

This map shows the geographic impact of Farkas Sükösd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farkas Sükösd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farkas Sükösd more than expected).

Fields of papers citing papers by Farkas Sükösd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farkas Sükösd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farkas Sükösd. The network helps show where Farkas Sükösd may publish in the future.

Co-authorship network of co-authors of Farkas Sükösd

This figure shows the co-authorship network connecting the top 25 collaborators of Farkas Sükösd. A scholar is included among the top collaborators of Farkas Sükösd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farkas Sükösd. Farkas Sükösd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pankotai, Tibor, et al.. (2024). LINE-1 ORF1p is a Promising Biomarker in Cervical Intraepithelial Neoplasia Degree Assessment. International Journal of Gynecological Pathology. 44(1). 22–30. 1 indexed citations
2.
Tóth, Arnold, et al.. (2024). First Results on the Presence of Mycotoxins in the Liver of Pregnant Fallow Deer (Dama dama) Hinds and Fetuses. Animals. 14(7). 1039–1039. 2 indexed citations
3.
Radics, Bence, Zsolt Bella, Ágnes Zsófia Kovács, et al.. (2024). Novel biomarkers of mitochondrial dysfunction in Long COVID patients. GeroScience. 47(2). 2245–2261. 10 indexed citations
4.
Sükösd, Farkas, et al.. (2024). Novel method for detecting frequent TERT promoter hot spot mutations in bladder cancer samples. Clinical and Experimental Medicine. 24(1). 192–192.
5.
Újfaludi, Zsuzsanna, et al.. (2024). Complex treatment of residual metastatic germ cell cancer: A single center experience. Journal of Biotechnology. 389. 61–67. 1 indexed citations
6.
Révész, János, et al.. (2023). Correlation between fibroblast growth factor receptor mutation, programmed death ligand-1 expression and survival in urinary bladder cancer based on real-world data. Pathology & Oncology Research. 29. 1611077–1611077. 2 indexed citations
7.
Migh, Ede, Andrea Nagy, András Kriston, et al.. (2022). A versatile transposon-based technology to generate loss- and gain-of-function phenotypes in the mouse liver. BMC Biology. 20(1). 74–74. 1 indexed citations
8.
Újfaludi, Zsuzsanna, et al.. (2022). The clinical significance of epigenetic and RNAPII variabilities occurring in clear cell renal cell carcinoma as a potential prognostic marker. Translational Oncology. 20. 101420–101420. 2 indexed citations
10.
Tóth, Tímea, Tamás Balassa, Ferenc Kovács, et al.. (2018). Environmental properties of cells improve machine learning-based phenotype recognition accuracy. Scientific Reports. 8(1). 10085–10085. 13 indexed citations
11.
Tóth, Csaba, Farkas Sükösd, Esther Herpel, et al.. (2017). Expression of ERCC1, RRM1, TUBB3 in correlation with apoptosis repressor ARC, DNA mismatch repair proteins and p53 in liver metastasis of colorectal cancer. International Journal of Molecular Medicine. 40(5). 1457–1465. 12 indexed citations
12.
Sükösd, Farkas, Béla Iványi, & László Pajor. (2014). Accurate Determination of the Pathological Stage with Gross Dissection Protocol for Radical Cystectomy. Pathology & Oncology Research. 20(3). 677–685. 2 indexed citations
13.
Sejben, István, et al.. (2013). Papillary renal cell carcinoma embedded in an oncocytoma: Case report of a rare combined tumour of the kidney. Canadian Urological Association Journal. 7(7-8). 513–513. 15 indexed citations
14.
Németh, I, András Rosztóczy, F Izbéki, et al.. (2011). A renewed insight into Barrett's esophagus: comparative histopathological analysis of esophageal columnar metaplasia. Diseases of the Esophagus. 25(5). 395–402. 6 indexed citations
15.
Sükösd, Farkas, et al.. (2003). Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma.. PubMed. 63(2). 455–7. 57 indexed citations
16.
Wilhelm, Mónica, et al.. (2002). Somatic mitochondrial DNA mutations in human chromophobe renal cell carcinomas. Genes Chromosomes and Cancer. 35(3). 256–260. 46 indexed citations
17.
Sükösd, Farkas, et al.. (2001). Mapping a tumor suppressor gene to chromosome 2p13 in metanephric adenoma by microsatellite allelotyping. Human Pathology. 32(1). 101–104. 28 indexed citations
18.
Sükösd, Farkas, et al.. (2000). [Parvovirus B19 infection in hydrops fetalis].. PubMed. 141(30). 1661–5. 5 indexed citations
19.
Sükösd, Farkas, et al.. (2000). High Density Deletion Mapping of Bladder Cancer Localizes the Putative Tumor Suppressor Gene Between Loci D8S504 and D8S264 at Chromosome 8p23.3. Laboratory Investigation. 80(7). 1089–1093. 40 indexed citations
20.
Magyarlaki, Tamás, et al.. (1999). Renal Cell Carcinoma and Paraneoplastic IgA Nephropathy. ˜The œNephron journals/Nephron journals. 82(2). 127–130. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026